IntelGenx’s Anti-Depressant, CPI-300, Receives FDA Approval
IntelGenx is at the forefront of the industry with CPI-300 being the only single dose 450 mg formulation of Bupropion HCl approved by the FDA.
IntelGenx is at the forefront of the industry with CPI-300 being the only single dose 450 mg formulation of Bupropion HCl approved by the FDA.
The introduction of delivering a drug on film might be the best thing since sliced bread. Similar to breath enhancement strips, this edible film technology is in studies to be used for erectile dysfunction, migraine, insomnia, bipolar disorder, and pain management!
Copyright © 2024 | WordPress Theme by MH Themes